Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170027 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
A Phase 3 study of Myocardial Ischemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT00170027: Completed Phase 3 study of Myocardial Ischemia, sponsored by Mayo Clinic.
NCT00170027 is a Phase 3 study of Myocardial Ischemia that has completed, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 2,129-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00170027, a Phase 3 study of Myocardial Ischemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive, non-contact diagnostic tool of obstructive coronary artery disease (CAD), and especially of cardiac ischemia. The overall objective of the present study is to demonstrate the efficacy of this MCG device in the diagnosis of lack of oxygen to an area of the heart (as in an Heart attack) in patients presenting with chest pain.
Conditions Studied
Interventions
- DEVICE Magnetocardiograph
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
What the finished NCT00170027 record still lists
NCT00170027 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,129-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Myocardial Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Magnetocardiograph is the first listed.
NCT00170027 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00170027 about?
NCT00170027 is a clinical study titled "Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease". A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive, non-contact diagnostic tool of obstructive coronary artery disease (CAD), and especially of cardiac...
What is the current status of trial NCT00170027?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2003-07. Estimated completion is 2007-07.
What conditions does trial NCT00170027 study?
This clinical trial studies the following conditions: Myocardial Ischemia.
What interventions are being tested in trial NCT00170027?
The interventions under investigation include: Magnetocardiograph (DEVICE).
Who is sponsoring clinical trial NCT00170027?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00170027 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00170027's enrollment target sits among peer trials
250 17th of 29 higher than 13 of 29 other Myocardial Ischemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Ischemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Electromechanical Mapping to Evaluate Heart Muscle
COMPLETED · Phase 3
-
Precision of the Magnetocardiographer for Data Aquision and Analysis.
COMPLETED · Phase 3
-
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
COMPLETED · Phase 3
-
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
COMPLETED · Phase 3
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia